Adthyza
Pricing Report NDC 24338-016-90

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Adthyza Thyroid (NDC 24338-016-90) is $0.61553 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 22, 2025.

As a provided by Azurity Pharmaceuticals, Inc., this medication is distributed in a 90 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.61553
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jan 22, 2025
Billable Units
90 EA
Estimated Package Price
$55.40
Data Status
As of Jan 14, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
24338-016-90
Description
90 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2024, the NADAC wholesale price for (NDC ) has moved within a range of $0.51013 to $0.63178 per EA. Over this 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.5101 - $0.6318
Market Volatility
23.85% Variance
Latest Trend
10.34%
Date Unit Price Unit Source Method Rate
Jan 22, 2025 $0.61553 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 22, 2025 $0.61553 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Dec 18, 2024 $0.55786 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 20, 2024 $0.55705 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Oct 23, 2024 $0.52436 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 18, 2024 $0.51013 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 21, 2024 $0.51013 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 17, 2024 $0.61994 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 22, 2024 $0.63178 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 22, 2024 $0.63178 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Apr 17, 2024 $0.63178 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026